Zoledronic acid‐induced oxidative damage and endoplasmic reticulum stress‐mediated apoptosis in human embryonic kidney (HEK‐293) cells
Zoledronic acid, a nitrogen‐containing bisphosphonate drug, is used for the treatment of
osteoporosis, Paget's disease of bone, and tumor‐induced osteolysis. Zoledronic acid has …
osteoporosis, Paget's disease of bone, and tumor‐induced osteolysis. Zoledronic acid has …
Zoledronic acid-induced oxidative damage and endoplasmic reticulum stress-mediated apoptosis in human embryonic kidney (HEK-293) cells
M Kara, T Boran, E Öztaş… - … of biochemical and …, 2022 - pubmed.ncbi.nlm.nih.gov
Zoledronic acid, a nitrogen-containing bisphosphonate drug, is used for the treatment of
osteoporosis, Paget's disease of bone, and tumor-induced osteolysis. Zoledronic acid has …
osteoporosis, Paget's disease of bone, and tumor-induced osteolysis. Zoledronic acid has …
Zoledronic acid‐induced oxidative damage and endoplasmic reticulum stress‐mediated apoptosis in human embryonic kidney (HEK‐293) cells
M Kara, T Boran, E Öztaş, AT Jannuzzi… - Journal of Biochemical …, 2022 - infona.pl
Zoledronic acid, a nitrogen‐containing bisphosphonate drug, is used for the treatment of
osteoporosis, Paget's disease of bone, and tumor‐induced osteolysis. Zoledronic acid has …
osteoporosis, Paget's disease of bone, and tumor‐induced osteolysis. Zoledronic acid has …
Zoledronic acid-induced oxidative damage and endoplasmic reticulum stress-mediated apoptosis in human embryonic kidney (HEK-293) cells
M Kara, T Boran, E Öztaş, A Jannuzzi… - JOURNAL OF …, 2022 - avesis.istanbul.edu.tr
Zoledronic acid, a nitrogen-containing bisphosphonate drug, is used for the treatment of
osteoporosis, Paget's disease of bone, and tumor-induced osteolysis. Zoledronic acid has …
osteoporosis, Paget's disease of bone, and tumor-induced osteolysis. Zoledronic acid has …
Zoledronic acid‐induced oxidative damage and endoplasmic reticulum stress‐mediated apoptosis in human embryonic kidney (HEK‐293) cells.
M Kara, T Boran, E Öztaş, AT Jannuzzi… - … of Biochemical & …, 2022 - search.ebscohost.com
Zoledronic acid, a nitrogen‐containing bisphosphonate drug, is used for the treatment of
osteoporosis, Paget's disease of bone, and tumor‐induced osteolysis. Zoledronic acid has …
osteoporosis, Paget's disease of bone, and tumor‐induced osteolysis. Zoledronic acid has …
Zoledronic acid-induced oxidative damage and endoplasmic reticulum stress-mediated apoptosis in human embryonic kidney (HEK-293) cells.
M Kara, T Boran, E Öztaş, AT Jannuzzi… - … of Biochemical and …, 2022 - europepmc.org
Zoledronic acid, a nitrogen-containing bisphosphonate drug, is used for the treatment of
osteoporosis, Paget's disease of bone, and tumor-induced osteolysis. Zoledronic acid has …
osteoporosis, Paget's disease of bone, and tumor-induced osteolysis. Zoledronic acid has …